Fractional Chief Medical Officer

The Company is seeking a Fractional Chief Medical Officer to take on a pivotal role in the development of therapies for rare diseases, with a specific focus on the ophthalmology space. The successful candidate will be responsible for championing the Phase 3 protocol, leading the design and execution of the Phase 3 trial in multiple countries, and overseeing the CRO selection and site selection processes. This role also involves providing clinical and regulatory credibility in investor conversations, particularly during the company's next funding round. Applicants for the Fractional Chief Medical Officer position at the company should have a strong background in clinical R&D, with experience in executive leadership and a deep understanding of the requirements for successful Phase 3 trial design and execution. The role requires the ability to work closely with the founder and CEO, and to be a key representative of the company in high-stakes investor interactions. A medical degree and a proven track record in the pharmaceutical or biotechnology industry, particularly in the development of therapies for rare diseases, are essential. The ideal candidate will be a strategic thinker, a team player, and have excellent communication skills to effectively lead and collaborate with cross-functional teams.